pyrazines has been researched along with 1-anilino-8-naphthalenesulfonate in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (33.33) | 18.7374 |
| 1990's | 2 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nikkilä, EA; Taskinen, MR | 1 |
| Demacker, PN; Stalenhoef, AF; Stuyt, PM; Van 't Laar, A | 1 |
| Alberti, KG; Christie, AW; Emmison, N; Kraemer, FB; McCormick, DK; Yeaman, SJ | 1 |
| A-Rahim, YI; Beyer, KH; Vesell, ES | 1 |
| Dunn, PJ | 1 |
| Nandith, A; Ramachandran, A; Shetty, AS; Snehalath, C | 1 |
1 review(s) available for pyrazines and 1-anilino-8-naphthalenesulfonate
| Article | Year |
|---|---|
The importance of green chemistry in process research and development.
Topics: Biocatalysis; Fluorobenzenes; gamma-Aminobutyric Acid; Green Chemistry Technology; Lipase; Pharmaceutical Preparations; Pregabalin; Pyrazines; Pyrimidines; Rosuvastatin Calcium; Sitagliptin Phosphate; Solvents; Sulfonamides; Transaminases; Triazoles | 2012 |
2 trial(s) available for pyrazines and 1-anilino-8-naphthalenesulfonate
| Article | Year |
|---|---|
Effects of acipimox on serum lipids, lipoproteins and lipolytic enzymes in hypertriglyceridemia.
Topics: Adult; Cholesterol, HDL; Clinical Trials as Topic; Double-Blind Method; Humans; Hyperlipoproteinemia Type IV; Hyperlipoproteinemia Type V; Hypolipidemic Agents; Lipase; Lipoprotein Lipase; Lipoproteins, HDL; Male; Middle Aged; Phospholipids; Pyrazines; Random Allocation; Triglycerides | 1988 |
A comparative study of the effects of acipimox and clofibrate in type III and type IV hyperlipoproteinemia.
Topics: Adult; Aged; Apolipoprotein A-I; Apolipoprotein A-II; Apolipoproteins A; Apolipoproteins B; Cholesterol; Clofibrate; Female; Humans; Hyperlipoproteinemia Type III; Hyperlipoproteinemia Type IV; Hypolipidemic Agents; Lipase; Lipoprotein Lipase; Lipoproteins; Male; Middle Aged; Pyrazines; Triglycerides | 1985 |
3 other study(ies) available for pyrazines and 1-anilino-8-naphthalenesulfonate
| Article | Year |
|---|---|
Mechanism of anti-lipolytic action of acipimox in isolated rat adipocytes.
Topics: Adenosine Deaminase; Adipocytes; Animals; Cells, Cultured; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Glycerol; Hypolipidemic Agents; Isoproterenol; Kinetics; Lipase; Lipolysis; Male; Pyrazines; Rats; Rats, Wistar; Subcellular Fractions | 1996 |
Studies on pyrazinoylguanidine. 3. Downregulation of lipolysis in isolated adipocytes.
Topics: Adipocytes; Adrenergic beta-Agonists; Animals; Colforsin; Cyclic AMP; Down-Regulation; Glycerol; Guanidines; Hypoglycemic Agents; In Vitro Techniques; Isoproterenol; Lipase; Lipolysis; Male; Pertussis Toxin; Pyrazines; Rats; Rats, Sprague-Dawley; Virulence Factors, Bordetella | 1996 |
Treatment with DPP-4 inhibitors does not increase the chance of pancreatitis in patients with type 2 diabetes.
Topics: Adult; Aged; Amylases; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Female; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Lipase; Male; Middle Aged; Pancreatitis; Pyrazines; Retrospective Studies; Risk Assessment; Sitagliptin Phosphate; Triazoles | 2013 |